SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement. Part II. Mitral Valve

[...]with the FDA having just approved these devices, the writing committee and participating societies believe that the recommendations listed in this report serve as an appropriate starting point. Since there is a strong consensus that these new valve therapies are best performed using a team appr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2014-10, Vol.64 (14), p.1515-1526
Hauptverfasser:	Tommaso, Carl L., MD, MSCAI, Fullerton, David A., MD, Feldman, Ted, MD, FESC, FACC, MSCAI, Dean, Larry S., MD, MSCAI, FACC, FAHA, Hijazi, Ziyad M., MD, MPH, MSCAI, FACC, FAAP, Horlick, Eric, MDCM, FRCPC, FSCAI, Weiner, Bonnie H., MD, MSEC, MBA, MSCAI, Zahn, Evan, MD, FACC, FSCAI, Cigarroa, Joaquin E., MD, FACC, Ruiz, Carlos E., MD, PhD, MSCAI, Bavaria, Joseph, MD, Mack, Michael J., MD, Cameron, Duke E., MD, Bolman, R. Morton, MD, Miller, D. Craig, MD, Moon, Marc R., MD, Mukherjee, Debabrata, MD, FACC, Trento, Alfredo, MD, Aldea, Gabriel S., MD, Bacha, Emile A., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aortic Valve Stenosis - surgery Cardiac Catheterization Cardiac Surgical Procedures - methods Cardiology Cardiology - standards Cardiovascular Cardiovascular disease Clinical Competence - standards Colleges & universities Heart Valve Diseases - surgery Heart Valve Prosthesis Implantation - instrumentation Heart Valve Prosthesis Implantation - standards Hospitals Hospitals - standards Humans Internal Medicine Mitral Valve - surgery Patient Care Team - standards Physicians Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...]with the FDA having just approved these devices, the writing committee and participating societies believe that the recommendations listed in this report serve as an appropriate starting point. Since there is a strong consensus that these new valve therapies are best performed using a team approach, these credentialing criteria may be best applied at the institutional level. The current pool of trained individuals is composed predominantly of those who have participated in industry-sponsored trials aimed at device approval. [...]the translation of currently available experiences with transcatheter valve therapies to the "real world" has yet to be evaluated in the United States.\n Jude Medicalb None None Hersh Maniar
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2014.05.005